Angelique Regnier-Golanov, PhD, is a senior scientist in the Neurosurgery Department of the Houston Methodist Hospital. She has a strong expertise in neuroinflammation, microcirculation and remote neuronal damage after epilepsy, as she worked on an original model of temporal lobe epilepsy of thalamic origin during her PhD, in Paris VII University. She pursued a post-doctorate on the effects of NR2B-containing NMDARs in the prevention of epileptic seizures development after traumatic brain injury at the Uniformed Services University in Bethesda, MD. As a postdoctoral fellow at Baylor College of Medicine, she carried two different projects, the effects of mTOR inhibitor on neurocognitive behavior and protein translation in temporal lobe epilepsy as well as quantitative EEG changes in different animal models of epilepsy.
She had the chance to join the Laboratory of Cerebrovascular Research at the Department of Neurosurgery, where she integrated her previous experience in epilepsy studies to investigate primarily long-term consequences of subarachnoid hemorrhage including abnormalities of cerebrospinal fluid flow. During her tenure, she acquired a unique set of “in vivo” and “in vitro” skills in neuroscience and neurophysiology that make her a uniquely qualified investigator. In the present laboratory, she successfully conducted behavioral and transcriptomics experiments that have been published in peer-reviewed journals. Furthermore, she was fortunate to be chosen to participate in the hands-on Cajal training in 2019, “Brain homeostasis and neurovascular coupling,” which trained her in the theoretical and practical state-of-the art in this multifaceted field.